IDO1 and brain neoplasm: Importantly, it has yet to be determined whether this finding holds true in recurrent GBM and this may be an important clinical consideration since our laboratory has experimental evidence from a model of spontaneously forming glioma suggesting that IDO1 functions differently in brain tumors depending on the newly diagnosed vs. recurrent context (unpublished observation).